blinatumomab

Ligand id: 7384

Name: blinatumomab

Classification
Compound class Antibody
Approved drug? Yes (FDA (2014))
International Nonproprietary Names
INN number INN
9028 blinatumomab
Synonyms
Blincyto® | bscCD19xCD3 | MEDI-538 | MT-103 | MT103 [1]
Database Links
Specialist databases
IMGT/mAb-DB 101
Other databases
PubChem SID 178103956
Search PubMed clinical trials blinatumomab
Search PubMed titles blinatumomab
Search PubMed titles/abstracts blinatumomab
Wikipedia Blinatumomab
Comments
Blinatumomab is a monoclonal antibody with anti-cancer effects. Its mechanism of action classifies this antibody as a member of the bi-specific T-cell engager (BiTE®) group of engineered antibodies.
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record.